Integrated Imaging Probe and Bispecific Antibody Development Enables <i>In Vivo</i> Targeting of Glypican-3–Expressing Hepatocellular Carcinoma

Peiman Habibollahi, Alexey Gurevich, James Z. Hui, Kelly Weinfurtner, George McClung, Justin Adler, Michael C. Soulen, David E. Kaplan, Gregory J. Nadolski, Stephen J. Hunt, Andrew Tsourkas, Terence P. Gade

Open source

DOI: 10.1158/1535-7163.mct-23-0470
Published: 2024-09-23
Container: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-23-0470,
  title = {Integrated Imaging Probe and Bispecific Antibody Development Enables
                    <i>In Vivo</i>
                    Targeting of Glypican-3–Expressing Hepatocellular Carcinoma},
  author = {Peiman Habibollahi and Alexey Gurevich and James Z. Hui and Kelly Weinfurtner and George McClung and Justin Adler and Michael C. Soulen and David E. Kaplan and Gregory J. Nadolski and Stephen J. Hunt and Andrew Tsourkas and Terence P. Gade},
  year = {2024},
  journal = {Molecular Cancer Therapeutics},
  doi = {10.1158/1535-7163.mct-23-0470},
  url = {https://doi.org/10.1158/1535-7163.mct-23-0470}
}

RIS

TY  - JOUR
TI  - Integrated Imaging Probe and Bispecific Antibody Development Enables
                    <i>In Vivo</i>
                    Targeting of Glypican-3–Expressing Hepatocellular Carcinoma
AU  - Peiman Habibollahi
AU  - Alexey Gurevich
AU  - James Z. Hui
AU  - Kelly Weinfurtner
AU  - George McClung
AU  - Justin Adler
AU  - Michael C. Soulen
AU  - David E. Kaplan
AU  - Gregory J. Nadolski
AU  - Stephen J. Hunt
AU  - Andrew Tsourkas
AU  - Terence P. Gade
PY  - 2024
JO  - Molecular Cancer Therapeutics
DO  - 10.1158/1535-7163.mct-23-0470
UR  - https://doi.org/10.1158/1535-7163.mct-23-0470
ER  -

APA

Habibollahi, P., Gurevich, A., Hui, J. Z., Weinfurtner, K., McClung, G., Adler, J., Soulen, M. C., Kaplan, D. E., Nadolski, G. J., Hunt, S. J., Tsourkas, A., & Gade, T. P. (2024). Integrated Imaging Probe and Bispecific Antibody Development Enables <i>In Vivo</i> Targeting of Glypican-3–Expressing Hepatocellular Carcinoma. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-23-0470

Source records

crossref · retrieved 2026-09-26T15:24:29.455Z